Sample size reestimation: A review and recommendations

Drug Information Journal

Volumn 40, Issue 4, 2006, Pages 475-484

  Chuang Stein, Christy ^a   Anderson, Keaven ^b   Gallo, Paul ^c   Collins, Sylva ^d  

^a PFIZER INC   (United States)

^b Merck

^c NOVARTIS   (Switzerland)

^d FBC Consulting

Author keywords

Adaptive design; Blinded and unblinded estimation; Combination test; Group sequential design

Indexed keywords

CLINICAL RESEARCH; CLINICAL STUDY; DRUG EFFICACY; DRUG SAFETY; METHODOLOGY; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; SAMPLING;

EID: 33750858668     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/216847900604000413     Document Type: Review

References (30)

1. Shih WJ. Sample size re-estimation - Journey for a decade. Stat Med. 2001;20:515-518.
2. Mehta CR, Patel NR. Adaptive, group sequential and decision theoretic approaches to sample size determination. Stat Med. 2006; in press.
3. Offen W, Chuang-Stein C, Dmitrienko A, et al. Multiple co-primary endpoints: medical and statistical solutions. Drug Inf J. 2006; in press.
4. Gallo P, Chuang-Stein C, Dragalin V, Gaydos B, Krams M, Pinheiro J. Adaptive designs in clinical drug development-an executive summary of the PhRMA working group. J Biopharm Stat. 2006; 16:275-283.
5. Wald A. Sequential Analysis. New York: Dover; 1947.
6. Siegmund D. Sequential Analysis: Tests and Confidence Intervals. New York: Springer; 1985.
7. Jennison C, Turnbull B. Group Sequential Methods With Applications to Clinical Trials. Boca Raton, FL: Chapman and Hall/CRC; 1999.
8. Gould AL. Planning and revising the sample size for a trial. Stat Med. 1995;14:1039-1051.
9. Friede T, Kieser M. Sample size recalculation for binary data in internal pilot study designs. Pharm Stat. 2004;3:269-279.
10. Gould AL. Sample size re-estimation: recent developments and practical considerations. Stat Med. 2001;20:2625-2643.
11. Kieser M, Friede T. Simple procedures for blinded sample size adjustment that do not affect the type I error rate. Stat Med. 2003;22:3571-3581.
12. ICH E-9 Expert Working Group. Statistical principles for clinical trials (ICH Harmonized Tripartite Guideline E-9). Stat Med. 1999;18:1905-1942.
13. Mehta C, Tsiatis AA. Flexible sample size considerations using information-based interim monitor. Drug Inf J. 2001;35:1095-1112.
14. Posch M, Bauer P, Brannath W. Issues in designing flexible trials. Stat Med. 2003;22:953-969.
15. Proschan MA. Two-stage sample size re-estimation based on a nuisance parameter. J Biopharm Stat. 2005;15:559-574.
16. Tsiatis AA, Mehta C. On the inefficiency of the adaptive design for monitoring clinical trials. Biometrika. 2003;20:367-378.
17. Burman C-F, Sonesson C. Are flexible designs sound? Biometrics 2006;62:1-6.
18. Jennison C, Turnbull BW. Adaptive and non-adaptive group sequential tests. Biometrika. 2006; 93:1-21.
19. Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics. 1999;55:1286-1290.
20. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics 1995;51:1315-1324.
21. Cui L, Hung HMJ, Wang SJ. Modification of sample size in group sequential clinical trials. Biometrics. 1999;55:853-857.
22. Jennison C, Turnbull B. Mid-course sample size modification in clinical trials based on the observed treatment effect. Stat Med. 2003;22:971-993.
23. Liu Q, Chi GY. On sample size and inference for two-stage adaptive designs. Biometrics. 2001;57: 172-177.
24. Bauer P, Konig F. The resassessment of trial perspectives from interim data-a critical view. Stat Med. 2006;25:23-36.
25. Jennison C, Turnbull BW. Efficient group sequential designs when there are several effect sizes under consideration. Stat Med. 2006;25:917-932.
26. Lokhnygina Y. Topics in Design and Analysis of Clinical Trials [dissertation]. Raleigh, NC: North Carolina State Department of Statistics; 2004.
27. Banerjee A, Tsiatis AA. Adaptive two-stage designs in phase II clinical trials. Stat Med. 2006; in press.
28. Friede T, Kieser M. A comparison of methods for adaptive sample size adjustment. Stat Med. 2001;20:3861-3873.
29. Berry DA. Statistical innovations in cancer research. In Holland J, Frei E III, Kufe D, et al., eds. Cancer Medicine e.7. London: Decker; 2005:411-425.
30. Dmitrienko A, Molenberghs G, Chuang-Stein C, Offen W. Analysis of Clinical Trials Using SAS: A Practical Guide. Cary, NC: SAS Institute; 2005.